Brenda Eap, PhD

557 posts

Brenda Eap, PhD banner
Brenda Eap, PhD

Brenda Eap, PhD

@beappbeapp

VP of Comms & Partnerships @theA4LI | Biogerontologist | @BuckInstitute & @USCLeonardDavis | Studied ketone bodies @GeriSciDoc |

Katılım Eylül 2021
521 Takip Edilen609 Takipçiler
Brenda Eap, PhD retweetledi
The Alliance for Longevity Initiatives (A4LI)
🧠 Longevity Fact of the Week 12.4 years. That's the average gap between lifespan and healthspan in the United States. In other words, the average American spends more than 12 years living with disease or disability before the end of life. While we have made remarkable progress in helping people live longer, the next challenge is helping people stay healthier for longer. At A4LI, we have made it our mission to advance policies that accelerate the development of therapies targeting the biology of aging, with the goal of extending not just lifespan, but healthspan as well. 📖 Learn more about the research behind the healthspan gap here: pmc.ncbi.nlm.nih.gov/articles/PMC11…
The Alliance for Longevity Initiatives (A4LI) tweet media
English
1
7
10
412
Brenda Eap, PhD
Brenda Eap, PhD@beappbeapp·
@theA4LI I would like to see our healthcare system prioritize earlier health screenings as a preventive measure.
English
0
0
0
23
The Alliance for Longevity Initiatives (A4LI)
With the oldest Baby Boomers turning 80 this year, our nation is entering a major demographic shift. As more Americans live longer than previous generations, we must look beyond lifespan alone and focus on helping people live healthier, more independent lives free from the burden of chronic disease. Learn more about this shift here: pewresearch.org/short-reads/20… At A4LI, we are working to advance policies that accelerate the development of therapies targeting the biology of aging. Extending healthy lifespan is about more than adding years to life. It’s about ensuring that those added years are healthier, more active, and free from the growing impact of age-related disease. As America's population continues to age, what do you think should be our nation's top priority to help people live healthier, longer lives? We'd love to hear your thoughts in the comments below.
The Alliance for Longevity Initiatives (A4LI) tweet media
English
3
4
12
368
Brenda Eap, PhD
Brenda Eap, PhD@beappbeapp·
A great recap if you couldn’t join us last week! Thanks for the opportunity @LongevityTech!
The Alliance for Longevity Initiatives (A4LI)@theA4LI

Last week, leaders in academia, longevity biotech, and policymakers came together in Washington, D.C. for our largest H-SPAN Summit to date. In an article for @LongevityTech, A4LI Vice President of Communications & Partnerships Dr. Brenda Eap reflects on this year’s Summit, from discussions with federal regulators and Members of Congress to the policy priorities that will shape the future of healthy longevity. You can read the full article here: longevity.technology/news/us-longev…

English
0
0
2
139
Brenda Eap, PhD retweetledi
The Alliance for Longevity Initiatives (A4LI)
Last week, we hosted our biggest and most impactful D.C. Summit yet. Across three days, we welcomed 250+ attendees, brought together 60+ leaders across the biotech and policymaking space, and facilitated 40+ meetings between longevity stakeholders and Members of Congress. That is why NOW is the time we capitalize on this momentum. Here’s how you can help: 1️⃣ Back Our Petitions Pledge your support for our White Papers on Action Network (actionnetwork.org/groups/the-all…) to help key decision makers understand the importance of longevity science. 2️⃣ Share with your Network Every signature helps. Help us raise awareness for these initiatives. Thank you to everyone who attended this year’s Summit, as well as all of you who have supported us over the years. None of this would be possible without you. Together, we can create a world in which everyone can live healthier, longer lives.
The Alliance for Longevity Initiatives (A4LI) tweet media
English
0
4
17
415
Brenda Eap, PhD
Brenda Eap, PhD@beappbeapp·
@theA4LI We now have hundreds of companies working on targeting the biology of aging and now with @ARPA_H PROSPR working on intrinsic capacity, incorporating this would be so timely.
English
0
1
2
53
The Alliance for Longevity Initiatives (A4LI)
𝐓𝐡𝐞 𝐅𝐃𝐀'𝐬 𝐫𝐞𝐠𝐮𝐥𝐚𝐭𝐨𝐫𝐲 𝐬𝐲𝐬𝐭𝐞𝐦 𝐰𝐚𝐬 𝐛𝐮𝐢𝐥𝐭 𝐟𝐨𝐫 𝐨𝐧𝐞 𝐝𝐫𝐮𝐠, 𝐨𝐧𝐞 𝐝𝐢𝐬𝐞𝐚𝐬𝐞. But the science is evolving. Researchers are increasingly developing therapies that target the shared biological mechanisms underlying multiple age-related diseases. Yet these therapies must still navigate separate regulatory pathways for each indication, creating unnecessary costs, delays, and uncertainty. As Congress prepares for PDUFA VIII, we are proposing the Multi-Disease Therapeutic Designation (MDTD): a new FDA expedited designation for therapies designed to address multiple serious diseases through a common biological mechanism. Our proposal would: • Require no new appropriations • Maintain existing FDA safety and efficacy standards • Build on the success of programs like RMAT and Breakthrough Therapy designation • Create a clearer regulatory pathway for geroscience and longevity biotechnology America has long led the world in biomedical innovation. Modernizing our regulatory framework can help ensure that leadership continues as the next generation of therapies reaches the clinic. 𝐃𝐨 𝐲𝐨𝐮 𝐭𝐡𝐢𝐧𝐤 𝐭𝐡𝐞 𝐅𝐃𝐀 𝐧𝐞𝐞𝐝𝐬 𝐚 𝐩𝐚𝐭𝐡𝐰𝐚𝐲 𝐬𝐩𝐞𝐜𝐢𝐟𝐢𝐜𝐚𝐥𝐥𝐲 𝐝𝐞𝐬𝐢𝐠𝐧𝐞𝐝 𝐟𝐨𝐫 𝐦𝐮𝐥𝐭𝐢-𝐝𝐢𝐬𝐞𝐚𝐬𝐞 𝐭𝐡𝐞𝐫𝐚𝐩𝐢𝐞𝐬? 𝐋𝐞𝐭 𝐮𝐬 𝐤𝐧𝐨𝐰 𝐢𝐧 𝐭𝐡𝐞 𝐜𝐨𝐦𝐦𝐞𝐧𝐭𝐬. 𝐑𝐞𝐚𝐝 𝐭𝐡𝐞 𝐟𝐮𝐥𝐥 𝐩𝐫𝐨𝐩𝐨𝐬𝐚𝐥 𝐚𝐧𝐝 𝐬𝐢𝐠𝐧 𝐨𝐧 𝐲𝐨𝐮𝐫 𝐬𝐮𝐩𝐩𝐨𝐫𝐭: actionnetwork.org/petitions/next…
The Alliance for Longevity Initiatives (A4LI) tweet media
English
5
9
27
1.6K
Brenda Eap, PhD
Brenda Eap, PhD@beappbeapp·
Last chance and we mean it!!!!
The Alliance for Longevity Initiatives (A4LI)@theA4LI

This is your final invitation to join us at the H-SPAN Summit D.C. Registration closes this week. If you are serious about the future of longevity, this is the one event you don't want to miss. Here is a snapshot of the schedule you're about to miss out on: 📅 Day 1: Scientific Breakthroughs An immersive deep dive into the longevity landscape with insights from @H_L_Clinic, @GenerationLab_ , @X_Therma, @FibroBiologics, @MatterBio, EdenRoc Sciences, Georgetown University Medical Center, and @altos_labs. Plus, an invaluable closing keynote by the honorable Leroy Hood (@PhenomeHealth). 📅 Day 2: Policy & Regulation We shift the focus entirely to the critical policy levers driving innovation. You’ll hear firsthand from @LMZeta (@US_FDA), @DrAliciaJackson (@ARPA_H), invited speaker @DrOz, @cole4nh (NH House of Representatives), @RepKevinMullin, and the co-chair of the Congressional Longevity Science Caucus, @RepPaulTonko. Grab your full or single-day ticket before the link closes: a4li.org/h-span-summit-…

English
0
1
2
105
Kris Barnes
Kris Barnes@KrisMBarnes·
Open-source aside, if companies (…) decide that their best AI biology capabilities are too powerful for unvetted users, it’ll be important to be transparent & make the process to get access quick/cheap/efficient. To do otherwise really hurts the democratization of science
English
3
0
2
46
Brenda Eap, PhD retweetledi
The Alliance for Longevity Initiatives (A4LI)
Our H-SPAN Summit DC is just around the corner. This year, we’re building on last year’s conversation about cross-agency alignment in funding and regulatory frameworks for longevity. We are thrilled to close Day 2 of the Summit with a landmark session: “Building the Framework: Policy Levers for Longevity Innovation.” For the first time, senior administration leaders and Members of Congress will join in a singular forum to discuss current federal initiatives and legislative levers that set out to make healthy longevity a national priority and achieve a true "longevity dividend." Featured speakers for this policy-focused second day include: •Dr. Mehmet Oz (Tentative), Administrator of the Centers for Medicare & Medicaid Services (CMS) •Lowell M. Zeta, Acting Chief of Staff and Deputy Commissioner for Strategic Initiatives, U.S. Food and Drug Administration (FDA) •Dr. Alicia Jackson, Director of the Advanced Research Projects Agency for Health (ARPA-H) •Congressman Kevin Mullin (CA-14), Representative of the Bay Area Longevity Biotech Ecosystem •Congressman Jim McGovern (MA-2), Ranking Member of the House Rules Committee and Champion for Nutrition and Healthy Aging Policy •Congressman Paul Tonko (NY-20), Co-chair of the Congressional Longevity Science Caucus
The Alliance for Longevity Initiatives (A4LI) tweet media
English
1
5
14
754
Brenda Eap, PhD retweetledi
The Alliance for Longevity Initiatives (A4LI)
Russia has committed $26 billion to longevity science, while China is advancing large-scale stem cell anti-aging trials and expanding aggressive investment in regenerative medicine and longevity biotechnology. Scientific leadership in longevity is rapidly becoming a defining frontier of global competitiveness. The United States cannot afford to sit on the sidelines. Join our letter campaign: actionnetwork.org/letters/the-us…
English
0
11
21
1.9K
Brenda Eap, PhD
Brenda Eap, PhD@beappbeapp·
A positive signal that the longevity ecosystem is gaining the critical visibility it needs from state lawmakers. Excited to get started!
The Alliance for Longevity Initiatives (A4LI)@theA4LI

What an unforgettable day! Yesterday marked a monumental win for the geroscience field and the longevity industry. California Senate Resolution 104 passed the floor with a unanimous 35-0 vote! Joining the presentation on the Senate floor were Dylan Livingston (Founder and CEO of A4LI), Sonia Arrison (Chair of the A4LI Board), Dr. Joon Yun, Remy Gross, and Sean Curran. We are beyond grateful to @SenJoshBecker and Senator Akilah Weber Pierson for introducing this historic resolution. The Alliance for Longevity Initiatives is excited to get to work and collaborate with LeadingAGE California, California Life Sciences, and the California Chronic Care Coalition on forward-thinking policies that promote aging biology research and public-private collaboration. By integrating longevity strategies into California's public health framework, SR-104 will optimize healthspans while driving significant long-term cost savings for the state!

English
0
0
0
33
Brenda Eap, PhD retweetledi
The Alliance for Longevity Initiatives (A4LI)
HB 1735 has passed the New Hampshire Senate. The bill was amended during the legislative process, but its passage reflects growing recognition that patients and innovators deserve greater flexibility when pursuing promising longevity therapies. "The final bill is more limited than we originally hoped for, but it's encouraging to see states like New Hampshire continue engaging with these issues,” said Dylan V. Livingston, Founder and CEO of @theA4LI. “The reality is that patients are looking for more options, and policymakers across the country are increasingly willing to have that conversation." We are grateful to the many New Hampshire leaders who championed HB 1735, including Governor @KellyAyotte and @NHSpeaker Sherman Packard. We also extend our thanks to the stakeholders, advocates, and volunteers who dedicated their time and energy to supporting the legislation and advancing the conversation around patient access and medical innovation.
The Alliance for Longevity Initiatives (A4LI) tweet media
English
1
5
16
499
Brenda Eap, PhD
Brenda Eap, PhD@beappbeapp·
This resolution is a positive signal that the longevity ecosystem in CA is gaining critical visibility it needs!
The Alliance for Longevity Initiatives (A4LI)@theA4LI

On June 8th, A4LI and a strong representation of academic and biotechnology leaders in longevity will join CA Senator Josh Becker (@SenJoshBecker) as he presents Senate Resolution 104. SR 104 advocates for a fundamental shift in how California approaches public health and fiscal planning regarding the state's aging population. The resolution encourages state health and aging departments to integrate geroscience into public health programming while fostering collaboration among academia, health plans, and biotechnology firms to pilot innovative longevity medicines and gerotherapeutics. This is an incredible milestone for California, the leading state for investment, talent, and innovation in the longevity science field! Resolution Text: legiscan.com/CA/text/SR104/… #CA #Healthspan #LongevityScience #A4LI

English
0
0
1
31
The Alliance for Longevity Initiatives (A4LI)
On June 8th, A4LI and a strong representation of academic and biotechnology leaders in longevity will join CA Senator Josh Becker (@SenJoshBecker) as he presents Senate Resolution 104. SR 104 advocates for a fundamental shift in how California approaches public health and fiscal planning regarding the state's aging population. The resolution encourages state health and aging departments to integrate geroscience into public health programming while fostering collaboration among academia, health plans, and biotechnology firms to pilot innovative longevity medicines and gerotherapeutics. This is an incredible milestone for California, the leading state for investment, talent, and innovation in the longevity science field! Resolution Text: legiscan.com/CA/text/SR104/… #CA #Healthspan #LongevityScience #A4LI
The Alliance for Longevity Initiatives (A4LI) tweet media
English
5
9
21
755
Brenda Eap, PhD
Brenda Eap, PhD@beappbeapp·
@theA4LI Stellar lineup indeed! We have a few more announcements coming! 😏
English
0
0
3
29
The Alliance for Longevity Initiatives (A4LI)
The H-SPAN Summit D.C. is only ONE MONTH away! Join us as we bring together researchers, policymakers, innovators, and advocates working to accelerate progress against age-related diseases and advance the future of medicine. Registration and Agenda Here: a4li.org/h-span-summit-…
English
5
7
25
813
Brenda Eap, PhD retweetledi
The Alliance for Longevity Initiatives (A4LI)
Thank you for highlighting the momentum we have been building since our inaugural event in 2024, @LongevityTech! Incredible to see how far the conversation has moved from speculative science to serious national policy in just three years. Read it here: longevity.technology/news/h-span-re… @bioagelabs @RetroBio_ @KarlPfleger @soniaarrison @mkaeberlein @DrMikeRoizen @BuckInstitute @aubreydegrey
English
1
5
15
1.2K
Brenda Eap, PhD retweetledi
Matt Kaeberlein
Matt Kaeberlein@mkaeberlein·
I’m thrilled to announce my new podcast, Longevity Science with Matt Kaeberlein. Episode 1 is now live and takes a deep dive into the story of dinitrophenol (DNP) — an experimental weight loss drug linked to hundreds of deaths and a cautionary reminder of what can happen when enthusiasm for new therapies gets ahead of the science. Episode 2 drops Friday and features a Longevity Roundtable with @BKennedy_aging and @docmranney . We discuss proactive healthcare, rapamycin, peptides, epigenetic reprogramming, biological age testing, and where the field of longevity medicine may be headed next. My goal with this channel is simple: thoughtful, evidence-based conversations that separate signal from noise in the rapidly evolving world of longevity science. I hope you’ll check it out — and subscribe on YouTube, Spotify, or wherever you listen to podcasts. YouTube: @mkaeberlein" target="_blank" rel="nofollow noopener">youtube.com/@mkaeberlein Spotify: open.spotify.com/show/7DRRH5lfL…
English
2
8
83
7.6K
Brenda Eap, PhD retweetledi
The Alliance for Longevity Initiatives (A4LI)
The passage of HB 1734 and HB 1735 is a no-brainer, and it is disappointing how much pushback it is receiving from the “pro-business,” “pro-freedom” and “pro-life” Republicans on the Senate Health and Human Services Committee. There are countless lives that can be helped — from early stage chronic disease to rare disease patients, all of whom have no other options. If you live in NH, call your Senators and demand these bills get passed. If you know someone in NH, do the same. @KellyAyotte — thank you for your support, your leadership, and your ability to see things clearly and with reason. @roche4nh — you are making lives worse and actively hurting your state. As a pharmacist, you of all people should understand what’s at stake for patients who have run out of options. You still have a chance to get this right. Do the right thing.
Adam Sexton@AdamSextonWMUR

Gov. @KellyAyotte tells reporters she is supportive of bills moving forward in the legislature to expand right-to-try & expanded experimental access in New Hampshire. Supporters contend these bills could provide a biotech economic boost for the state. #NHPolitics #WMUR

English
4
5
18
1K
Brenda Eap, PhD retweetledi
The Alliance for Longevity Initiatives (A4LI)
The Alliance for Longevity Initiatives (A4LI) would like to provide an update regarding New Hampshire’s ongoing efforts to expand patient access to investigational medical treatments and strengthen the state’s position as a hub for biomedical innovation. This week, legislative language from HB1734 and HB1735 was successfully attached to SB504 through the amendment process in the New Hampshire House of Representatives, keeping these reforms active as negotiations continue. HB1734 would authorize the establishment of experimental treatment centers capable of offering eligible investigational therapies under state oversight, while HB1735 would expand New Hampshire’s Right to Try framework to include patients suffering from chronic and debilitating conditions We would especially like to thank House Speaker Sherman Packard (@NHSpeaker) and Majority Leader Jason Osborne (@Osborne4NH) for their leadership and continued support. Together, these proposals continue New Hampshire’s emergence as one of the most forward-looking states in the country on medical innovation, patient autonomy, and access to next-generation therapies. As the process continues, we encourage everyone to respectfully reach out to Senate President Sharon Carson, Senator Rochefort, and Senator Birdsell and urge them to support SB504 as amended during committee of conference negotiations. We look forward to continuing to work with lawmakers, patients, advocates, and innovators as this effort progresses.
The Alliance for Longevity Initiatives (A4LI) tweet media
English
2
6
22
514